Association of insurance types and outcomes in acute promyelocytic leukemia

Prajwal Dhakal, Utsav Joshi, Elizabeth Lyden, Avantika Pyakuryal, Krishna Gundabolu, Vijaya Raj Bhatt

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Understanding the association between insurance status and survival in an evolving US healthcare system remains a challenge but is essential to address healthcare disparities. We utilized National Cancer Database to evaluate the effects of insurance type on one-month mortality and overall survival (OS) in patients with acute promyelocytic leukemia. Among patients <65 years, one-month mortality was worse for uninsured patients and patients with Medicare compared to patients with private insurance. OS was similar between patients with private insurance and uninsured patients but worse for patients with Medicare and Medicaid/other government insurance. In multivariate analysis, older age and greater comorbidity burden conferred worse OS. For patients ≥65 years, insurance type did not affect one-month mortality and OS. Older age, greater comorbidity burden, and treatment at non-academic centers conferred worse one-month mortality and OS. Our results highlight healthcare disparities based on insurance types for both younger and older patients.

Original languageEnglish (US)
Pages (from-to)2627-2635
Number of pages9
JournalLeukemia and Lymphoma
Issue number11
StatePublished - 2022


  • Acute promyelocytic leukemia
  • health care disparities
  • insurance
  • mortality
  • overall survival

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research


Dive into the research topics of 'Association of insurance types and outcomes in acute promyelocytic leukemia'. Together they form a unique fingerprint.

Cite this